-
effectivehealthcare.ahrq.gov/health-topics/oxygen-therapy
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs022728-zhou-final-report-2018.pdf
January 01, 2018 - Distribute our methods and tool
Scope
Background and Context
Allergies are linked to a number of chronic … Psychiatric conditions and comorbidities were defined from the EHR and
-
www.ahrq.gov/sites/default/files/2024-07/zhou-report.pdf
January 01, 2024 - Distribute our methods and tool
Scope
Background and Context
Allergies are linked to a number of chronic … Psychiatric conditions and comorbidities were defined from the EHR and
used in multivariable logistic
-
cdsic.ahrq.gov/sites/default/files/2023-09/SMD%20PC%20CDS%20Performance%20Measurement%20Inventory%20User%20Guide_FINAL_9.19.23.pdf
January 01, 2023 - Design, effectiveness, and economic outcomes of
contemporary chronic disease clinical decision support … Development and validation of the
functional assessment of chronic illness therapy treatment satisfaction … Effectiveness of computerized clinical
decision support systems for asthma and chronic obstructive pulmonary
-
digital.ahrq.gov/sites/default/files/SMD%20PC%20CDS%20Performance%20Measurement%20Inventory%20User%20Guide_FINAL_9.19.23.pdf
August 01, 2023 - Design, effectiveness, and economic outcomes of
contemporary chronic disease clinical decision support … Development and validation of the
functional assessment of chronic illness therapy treatment satisfaction … Effectiveness of computerized clinical
decision support systems for asthma and chronic obstructive pulmonary
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/latent-tuberculosis-infection-screening
May 02, 2023 - disease. 5 , 6 Rates of progression may be higher in persons with certain risk factors or medical conditions … alcoholism, and drug addiction), use of immune-suppressing drugs such as tumor necrosis factor inhibitors or chronic
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/cre.pdf
September 26, 2019 - Other risk factors include intensive care unit
(ICU) stay, poor functional status, underlying medical
conditions … the preceding 3 months (odds ratio
[OR]: 1.64, 95% confidence interval (CI), 0.68 to 3.94, p=0.27), chronic … admission to
another hospital department
with a hospital stay of more
than 5 days,
immunosuppression, chronic … methods, supervised
adherence to the guidelines
via daily census reports on
carriers and their conditions
-
hcup-us.ahrq.gov/db/nation/nass/NASS_Introduction_2020.jsp
January 01, 2020 - Clinical Classifications Software Refined (CCSR)
Elixhauser Comorbidity Software Refined for ICD-10-CM
Chronic … Services and Procedures
Tools for ICD-9-CM
Clinical Classifications Software (CCS) for ICD-9-CM
Chronic … terms of the Data Use Agreement for Nationwide Databases; please refer to the DUA for full terms and conditions … sources were prohibited from providing HCUP with encounter records that indicated specific medical conditions … , such as HIV/AIDS or behavioral health conditions.
-
hcup-us.ahrq.gov/db/nation/nass/NASS_Introduction_2019.jsp
January 01, 2019 - Clinical Classifications Software Refined (CCSR)
Elixhauser Comorbidity Software Refined for ICD-10-CM
Chronic … Services and Procedures
Tools for ICD-9-CM
Clinical Classifications Software (CCS) for ICD-9-CM
Chronic … terms of the Data Use Agreement for Nationwide Databases; please refer to the DUA for full terms and conditions … sources were prohibited from providing HCUP with encounter records that indicated specific medical conditions … , such as HIV/AIDS or behavioral health conditions.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/3qpQqeeozW8nV3a4_BWntp
June 20, 2019 - Prevalence of
chronic hepatitis B and incidence of acute hepatitis B infection in human immu-
nodeficiency … Recommended adult immunization schedule by age group and medical
conditions—United States, 2003-2004. … In patients with untreated
chronic HIV infection, current U.S. guidelines either do not
recommend routine … Although interventions for chronic
HIV infection, particularly HAART, are associated with many
clinically … (exp leukocyte count/ and cd4.mp.) or exp cd4 lympho-
cyte count/
9. exp “pathological conditions, signs
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/major-depressive-disorder_research-protocol.pdf
November 24, 2014 - preventive activities3 as well as adherence to medical
treatment,4 and it increases the likelihood of chronic … conditions such as obesity, smoking,
sedentary lifestyles, diabetes, and cancer .5,6 MDD may be associated … with a general
increase in chronic disease.
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2017_Core.PDF
January 01, 2017 - DRG_NoPOA Frequency
Percent
of Total
189: PULMONARY EDEMA & RESPIRATORY FAILURE 77,166 1.08%
190: CHRONIC … OBSTRUCTIVE PULMONARY DISEASE W MCC 85,356 1.19%
191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE W CC 38,463 … 0.54%
192: CHRONIC OBSTRUCTIVE PULMONARY DISEASE W/O CC/MCC 20,871 0.29%
193: SIMPLE PNEUMONIA & PLEURISY
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2016_Core.PDF
January 01, 2016 - PLEURAL EFFUSION W/O CC/MCC 964 0.01%
189: PULMONARY EDEMA & RESPIRATORY FAILURE 65,661 0.92%
190: CHRONIC … OBSTRUCTIVE PULMONARY DISEASE W MCC 59,653 0.84%
191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE W CC 40,246 … 0.56%
192: CHRONIC OBSTRUCTIVE PULMONARY DISEASE W/O CC/MCC 23,447 0.33%
193: SIMPLE PNEUMONIA & PLEURISY
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2016_Core_Weighted.PDF
January 01, 2016 - PLEURAL EFFUSION W/O CC/MCC 4,820 0.01%
189: PULMONARY EDEMA & RESPIRATORY FAILURE 328,305 0.92%
190: CHRONIC … OBSTRUCTIVE PULMONARY DISEASE W MCC 298,265 0.84%
191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE W CC 201,230 … 0.56%
192: CHRONIC OBSTRUCTIVE PULMONARY DISEASE W/O CC/MCC 117,235 0.33%
193: SIMPLE PNEUMONIA &
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2017_Core_Weighted.PDF
January 01, 2017 - DRG_NoPOA Frequency
Percent
of Total
189: PULMONARY EDEMA & RESPIRATORY FAILURE 385,830 1.08%
190: CHRONIC … OBSTRUCTIVE PULMONARY DISEASE W MCC 426,780 1.19%
191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE W CC 192,315 … 0.54%
192: CHRONIC OBSTRUCTIVE PULMONARY DISEASE W/O CC/MCC 104,355 0.29%
193: SIMPLE PNEUMONIA &
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2016_MaskedStats_Core.PDF
January 01, 2016 - PLEURAL EFFUSION W/O CC/MCC 78 0.00%
189: PULMONARY EDEMA & RESPIRATORY FAILURE 11,907 0.38%
190: CHRONIC … OBSTRUCTIVE PULMONARY DISEASE W MCC 566 0.02%
191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE W CC 199 0.01% … 192: CHRONIC OBSTRUCTIVE PULMONARY DISEASE W/O CC/MCC 145 0.00%
193: SIMPLE PNEUMONIA & PLEURISY W
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2017_Core.PDF
January 01, 2017 - PLEURAL EFFUSION W/O CC/MCC 2,316 0.01%
189: PULMONARY EDEMA & RESPIRATORY FAILURE 197,134 1.10%
190: CHRONIC … OBSTRUCTIVE PULMONARY DISEASE W MCC 232,695 1.29%
191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE W CC 109,460 … 0.61%
192: CHRONIC OBSTRUCTIVE PULMONARY DISEASE W/O CC/MCC 60,018 0.33%
193: SIMPLE PNEUMONIA & PLEURISY
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2016_Core.PDF
January 01, 2016 - PLEURAL EFFUSION W/O CC/MCC 2,680 0.02%
189: PULMONARY EDEMA & RESPIRATORY FAILURE 161,298 0.94%
190: CHRONIC … OBSTRUCTIVE PULMONARY DISEASE W MCC 152,527 0.89%
191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE W CC 108,326 … 0.63%
192: CHRONIC OBSTRUCTIVE PULMONARY DISEASE W/O CC/MCC 64,410 0.37%
please refer to the section
-
www.ahrq.gov/cahps/faq/index.html
January 01, 2019 - Adding other items from the SF-12 or a Chronic Condition List adds very little to the ability to adjust
-
www.ahrq.gov/patient-safety/patients-families/consumer-exp/reporting/chapter6.html
August 01, 2022 - For example, a TEP member suggested that the Medicare Conditions of Participation (for health care facilities